Abstracts Archive - Page 1505 of 2425 - ACR Meeting Abstracts

Abstract Number: 1312 • 2016 ACR/ARHP Annual Meeting
Incidence of Reactive Arthritis, Uveitis and Conjunctivitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20 Years’ Two-Center Retrospective Study
Satoshi Inotani^1,2,3,4, Yoshinori Taniguchi⁵, Takashi Karashima⁶, Yasuhiko Yoshinaga⁷, Hirofumi Nishikawa⁸, Natsuki Maeda⁹, Shimpei Fujimoto⁸ and Yoshio Terada¹⁰, ¹internal medicine, Chikamori Hospital, Kochi, Japan, ²Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi medical school, Nankoku, Japan, ³Urology, Kochi medical school, Nankoku, Japan, ⁴Rheumatic Disease Center, Kurashiki Medical Center, Kurashiki, Japan, ⁵Endocrinology, Metabolism,Nephrology and Rheumatology, Kochi University, Kochi, Japan, ⁶Urology, Kochi University, Nankoku, Japan, ⁷Kurashiki Medical Center, Kurashiki, Japan, ⁸Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School, Nankoku, Japan, ⁹Endocrinology,Metabolism,Nephrology and Rheumatology, Kochi Medical School, Nankoku, Japan, ¹⁰Kochi University, Nankoku, Japan
Background/Purpose: To evaluate the incidence of reactive arthritis (ReA), uveitis and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy (iBCG). Methods: The…
Abstract Number: 1313 • 2016 ACR/ARHP Annual Meeting
Rheumatologic Diseases in HIV-Infected Patients in the Post-Antiretroviral Therapy Era: The County Experience
Muhsen Al-ani¹, Yasir Abdulqader¹, Robert Myers¹, Napatkamon Ayutyanont‎², Bikash Bhattarai² and Konstantinos Parperis³, ¹Internal Medicine, Maricopa Integrated Health System and University of Arizona College of Medicine, Phoenix Campus, phoenix, AZ, ²Research, Maricopa Integrated Health System, phoenix, AZ, ³Rheumatology, Maricopa Integrated Health System and University of Arizona College of Medicine, Phoenix Campus, phoenix, AZ
Background/Purpose: HIV infection has been associated with a plethora of rheumatologic diseases, however there are only few studies in the US analyzing the frequency of…
Abstract Number: 1314 • 2016 ACR/ARHP Annual Meeting
Characteristics of the Musculoskeletal Symptoms Observed Among Survivors of Ebola Virus Disease (EVD) in the Postebogui Cohort in Guinea
Yves-Marie PERS¹, Mamadou SALIOU SOW², Bernard TAVERNE³, Laura MARCH³, Jean-François ETARD³, Moumié BARRY⁴, Abdoulaye TOURE⁵ and Eric DELAPORTE³, ¹Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital Montpellier, MONTPELLIER, France, ²Infectious Disease, Donka University National Hospital, CONAKRY, Guinea, ³IRD UMI 233 INSERM U1175, University Montpellier, MONTPELLIER, France, ⁴Hôpital National Donka, CHU de Conakry, Service des Maladies Infectieuses et Tropicales, Conakry, Guinea, ⁵Department of Pharmacy, Conakry University, CONAKRY, Guinea
Background/Purpose: Previous studies showed that arthralgia and myalgia were the most common symptoms among Ebola virus disease (EVD) survivors. Nevertheless specific analyses of rheumatologic sequelea…
Abstract Number: 1315 • 2016 ACR/ARHP Annual Meeting
Methotrexate and TNF-Blockers for Post Chikungunya Chronic Arthritis : The Martinican Experience
Marie Blettery¹, Lauren Brunier-Agot², JULIA MARY³, Katlyne Polomat⁴, Florence MOINET⁴, Christophe Deligny⁵, Serge ARFI⁶, Georges JEAN BAPTISTE⁷ and Michel De Bandt⁸, ¹rheumatology, CHU Fort de France, Fort de France, Martinique, ²Internal medicine and rheumatology, Zobda Quitman Hospital, Fort de France, Martinique, ³RHEUMATOLOGY, CHU Fort de France, 97261, Martinique, ⁴Rheumatology and Internal Medicine, Zobda Quitman Hospital, Fort de France, Martinique, ⁵Zobda Quitman Hospital, Rheumatology and Internal Medicine, Fort de France, Martinique, ⁶University Hospital, CHU Fort de France, Fort de France, Martinique, ⁷RHEUMATOLOGY, CHU MARTINIQUE, FWI, Fort-de-France, Martinique, ⁸Rheumatology department, CHU Fort de France, Fort de France, France
Background/Purpose: To describe treatments in patients with chronic post-chikungunya polyarthritis seen during the Caribbean outbreak (December 2013 - January 2015). Methods: Patients were examined by…
Abstract Number: 1316 • 2016 ACR/ARHP Annual Meeting
Clinical Features and Outcomes of Prosthetic Joint Septic Arthritis: The Gender Effect
Mary Louise Fowler¹, Sarah B. Lieber², Andy Moore³, Robert Shmerling⁴ and Ziv Paz², ¹Boston University School of Medicine, Boston, MA, ²Beth Israel Deaconess Medical Center, Boston, MA, ³Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ⁴Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: In developed countries, certain health outcomes are worse among men. For example, in the US, life expectancy for men is 5 years shorter than…
Abstract Number: 1317 • 2016 ACR/ARHP Annual Meeting
Do Patients with MRSA-Positive Septic Arthritis Differ Clinically from Non-MRSA-Positive Counterparts?
Mary Louise Fowler¹, Kevin Byrne¹, Sarah B. Lieber², Andy Moore³, Robert Shmerling⁴ and Ziv Paz², ¹Boston University School of Medicine, Boston, MA, ²Beth Israel Deaconess Medical Center, Boston, MA, ³Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ⁴Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA
Do patients with MRSA-positive septic arthritis differ clinically from non-MRSA-positive counterparts? Mary Louise Fowler3, Kevin Byrne3, Sarah B. Lieber1, Andrew Moore2, Robert H. Shmerling1, Ziv…
Abstract Number: 1318 • 2016 ACR/ARHP Annual Meeting
Profile of Macrophage-Derived Cytokines and Chemokines of Patients with Chikungunya-Induced Chronic Arthralgia/Arthritis
Idali Martinez¹, Edwin Lopez¹, Zelma L. Rios¹ and Luis M. Vilá², ¹Department of Microbiology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, ²Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico
Background/Purpose: Chikungunya virus (CHIKV) caused a large epidemic in Puerto Rico in 2014 with more than 30,000 reported cases. Many of the affected individuals developed…
Abstract Number: 1319 • 2016 ACR/ARHP Annual Meeting
Chikungunya Fever in Patients on Biological and on Conventional Dmards Therapy – Results from the Brazilian Register Biobadabrasil
Aline Ranzolin¹, Angela Duarte², Claudia Marques³, Laurindo Rocha Jr⁴, Samia Araujo de Souza Studart⁵, José Caetano Macieira⁶, Monica Valeria Siqueira S de Vechi⁶, Lina Oliveira de Carvalho⁶, Ines Guimarães da Silveira⁷, Ieda Maria Magalhães Laurindo⁸ and BiobadaBrasil, ¹Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil, ²Internal Medicine, Hospital das Clínicas - UFPE, Recife, Brazil, ³Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, ⁴Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, ⁵Reumatologia, Hospital Geral de Fortaleza, Fortaleza, Brazil, ⁶Reumatologia, Hospital Federal de Sergipe, Aracaju, Brazil, ⁷Reumatologia, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil, ⁸Internal Medicine - Rheumatology, Faculdade de Medicina da Universidade Nove de Julho, São Paulo, Brazil
Background/Purpose: Chikungunya fever (CHIKF) is a systemic arboviral disease manifesting with fever, acute arthritis and rash. The acute symptoms can last for days but…
Abstract Number: 1320 • 2016 ACR/ARHP Annual Meeting
Chikungunya Fever Outbreak in Brazil: Preliminary Assessment in a Cohort of Patients with Rheumatological Manifestations
Claudia Marques¹, Nara Cavalcanti², Mariana Luna³, Paula Toche², Carolina Andrade², Andrea Dantas², Aline Ranzolin², Laurindo Rocha Jr⁴, Eutília Freire⁵, Pablo Cardoso⁶, Kamila Vilar⁷, Michelly Pereira⁸, Moacyr Rêgo⁸, Maira Pitta⁶ and Angela Duarte⁹, ¹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, ²Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil, ³Universidade Federal de Pernambuco, Recife, Brazil, ⁴Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, ⁵Universidade Federal da Paraíba, João Pessoa, Brazil, ⁶Departamento de Bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁷Departamento de bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁸Bioquimica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, PE, Brazil
Background/Purpose: Chikungunya virus (CHIKV) emerged in Brazil in September 2014. Since then the infection reached epidemic proportions in the country, paticularly in the Northeast region…
Abstract Number: 1321 • 2016 ACR/ARHP Annual Meeting
Distinguishing Features of Polymicrobial Septic Arthritis
Sarah B. Lieber¹, Andy Moore², Robert Shmerling³, Mary Louise Fowler⁴ and Ziv Paz¹, ¹Beth Israel Deaconess Medical Center, Boston, MA, ²Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ³Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ⁴Boston University School of Medicine, Boston, MA
Background/Purpose: Little is known about patients with polymicrobial septic arthritis (SA) and how they may differ from those with SA due to a single organism.…
Abstract Number: 1322 • 2016 ACR/ARHP Annual Meeting
Use of Biologics in Arthritis Patients with Hepatitis B and C ‏: A Multicentral Retrospective Case Series
Sultana Abdulaziz¹, Hessein Halabi², Mohammed Omair³, Suzan Attar⁴, Mohammed Shabrawishi⁵, Abdulwahab Neyazi⁶, Haneen Alnazzawi⁷, Noha Meraiani⁸ and Hani Almoallim⁹, ¹Dept of Medicine/Unit of Rheumatology, King Fahad Hospital, Jeddah, Saudi Arabia, ²Department of Medicine, King Faisal Specialist Hospital,, Jeddah, Saudi Arabia, ³Dept of Medicine, Div of Rheumatology, King Saud University, Riyadh, Saudi Arabia, ⁴Internal Medicine, FRCPC, ABIM, Professor in Medicine, Jeddah, Saudi Arabia, ⁵Department of Medicine, King Faisal Specialist Hospital, Jeddah, Saudi Arabia, ⁶Department of Medicine, King Abdullah Medical City, Jeddah, Saudi Arabia, ⁷King Faisal Specialist Hospital, JEDDAH, Saudi Arabia, ⁸Department of Medicine, National Guard Hospital, JEDDAH, Saudi Arabia, ⁹Department of Medicine, Umm Alqura University, Makkah, Saudi Arabia, Makkah, Saudi Arabia
Use of biologics in arthritis patients with Hepatitis B and C ‏: a multicentral retrospective case series Abstract Background/Purpose: Reactivation of viral hepatitis B…
Abstract Number: 1323 • 2016 ACR/ARHP Annual Meeting
Systemic Manifestations Associated with Parvovirus B19 Infection in Adults: A Retrospective Study in 23 Patients
Marion Dollat¹, Luc Mouthon², Gregoire Cormier³, Emilie Berthoux⁴, Alban Deroux⁵, Nathalie Costedoat-Chalumeau⁶ and François Lifermann⁷, ¹Hopital Cochin, Internal Medicine, Paris, France, ²Internal Medicine, Hopital Cochin, Paris, France, ³Rheumatology, CHD la Roche sur yon, La Roche Sur Yon, France, ⁴Centre Hospitaliser Saint Joseph Saint Luc, Lyon, Lyon, France, ⁵Internal Medicine, CHU Grenoble, Grenoble, France, ⁶Internal Medicine, Cochin University Hospital, Paris, France, ⁷CH Dax, Dax, France
Background/Purpose: Human parvovirus B19 (HPV-B19) is well known as a cause of erythema infectiosum during childhood, pure red cell aplasia in immunocompromised persons, transient aplastic…
Abstract Number: 1324 • 2016 ACR/ARHP Annual Meeting
The Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
Yasuhiro Suyama¹, Haruki Sawada², Yukihiko Ikeda³, Rui Kawato⁴, Sakura Tamaki⁴, Mitsumasa Kishimoto¹ and Masato Okada¹, ¹Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ²Immuno-rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ³Immune-Rheumatology center, St. Luke's International Hospital, Tokyo, Japan, ⁴Immuno rheumatology center, St. Luke's International Hospital, Tokyo, Japan
Background/Purpose: Active tuberculosis (TB) is one of the most devastating side effects of biologic agents use. Several guidelines for the prevention of biologic agents-related infections…
Abstract Number: 1325 • 2016 ACR/ARHP Annual Meeting
Musculoskeletal Manifestations in Ebola Survivors
Duane Pearson¹, Lisa Davis², John Frankhauser³ and Liron Caplan⁴, ¹Division of Rheumatology, University of Colorado, Aurora, CO, ²Div of Rheumatology, Denver Health, Denver, CO, ³Serving In Mission, Monrovia, Liberia, ⁴Div of Rheumatology, Denver VA and University of Colorado School of Medicine, Aurora, CO
Background/Purpose: Musculoskeletal complaints are common among survivors of Ebola Virus Disease (EVD) and can have clinical impacts beyond two years post-convalescence. The frequency of these…
Abstract Number: 1326 • 2016 ACR/ARHP Annual Meeting
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthropathy, Following Lyme Disease
Sheila Arvikar¹, Jameson Crowley¹, Katherine Sulka² and Allen C. Steere³, ¹Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA, ²Rheumatology Allergy and Immunology, Massachusetts General Hospital, Charlestown, MA, ³Center for Immunolgy and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Lyme arthritis (LA) usually responds to antibiotic therapy, though immune-mediated synovitis may persist after antibiotic treatment, usually confined to a previously infected joint,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].